We've found
1,870
archived clinical trials in
Pain
We've found
1,870
archived clinical trials in
Pain
Heart Rate Variability in Children With a Functional Gastrointestinal Disorder
Heart Rate Variability in Children With Abdominal Pain Related to a Functional Gastrointestinal Disorder: Relationship to Anxiety/Stress, Electrogastrography, and Rapid Water Loading
Status: Archived
Heart Rate Variability in Children With a Functional Gastrointestinal Disorder
Updated: 1/1/1970
Heart Rate Variability in Children With Abdominal Pain Related to a Functional Gastrointestinal Disorder: Relationship to Anxiety/Stress, Electrogastrography, and Rapid Water Loading
Status: Archived
Updated: 1/1/1970
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
Updated: 1/1/1970
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Updated: 1/1/1970
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
Updated: 1/1/1970
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Updated: 1/1/1970
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
Updated: 1/1/1970
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Updated: 1/1/1970
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
Updated: 1/1/1970
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Updated: 1/1/1970
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
Updated: 1/1/1970
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Updated: 1/1/1970
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
Updated: 1/1/1970
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Updated: 1/1/1970
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
Updated: 1/1/1970
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Updated: 1/1/1970
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
Updated: 1/1/1970
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Updated: 1/1/1970
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
Updated: 1/1/1970
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Updated: 1/1/1970
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
Updated: 1/1/1970
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Updated: 1/1/1970
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
Updated: 1/1/1970
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Updated: 1/1/1970
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
Updated: 1/1/1970
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Updated: 1/1/1970
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
Updated: 1/1/1970
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Updated: 1/1/1970
Efficacy of Inhaled Cannabis in Diabetic Painful Peripheral Neuropathy
Efficacy of Inhaled Cannabis in Diabetic Painful Peripheral Neuropathy
Status: Archived
Efficacy of Inhaled Cannabis in Diabetic Painful Peripheral Neuropathy
Updated: 1/1/1970
Efficacy of Inhaled Cannabis in Diabetic Painful Peripheral Neuropathy
Status: Archived
Updated: 1/1/1970
The Predictors and Patient Versus Parental Perceptions of Health-Related Quality of Life in Pediatric Chronic Pain
The Predictors and Patient Versus Parental Perceptions of Health-Related Quality of Life in Pediatric Chronic Pain
Status: Archived
The Predictors and Patient Versus Parental Perceptions of Health-Related Quality of Life in Pediatric Chronic Pain
Updated: 1/1/1970
The Predictors and Patient Versus Parental Perceptions of Health-Related Quality of Life in Pediatric Chronic Pain
Status: Archived
Updated: 1/1/1970
Study of T3 for the Treatment of Fibromyalgia
T3 for Fibromyalgia: a Pilot Double-blind Non-randomized Clinical Trial
Status: Archived
Study of T3 for the Treatment of Fibromyalgia
Updated: 1/1/1970
T3 for Fibromyalgia: a Pilot Double-blind Non-randomized Clinical Trial
Status: Archived
Updated: 1/1/1970
Nutrition and Coping Education for Symptom and Weight Management for Fibromyalgia
Lifestyle Modification Program for Overweight and Obese Fibromyalgia Patients
Status: Archived
Nutrition and Coping Education for Symptom and Weight Management for Fibromyalgia
Updated: 1/1/1970
Lifestyle Modification Program for Overweight and Obese Fibromyalgia Patients
Status: Archived
Updated: 1/1/1970
Developing Biomarkers for Fibromyalgia
Updated: 1/1/1970
Developing Biomarkers for Fibromyalgia
Status: Archived
Updated: 1/1/1970
Pain and Substance Use Disorders
Managing Chronic Pain in Veterans With Substance Use Disorders
Status: Archived
Pain and Substance Use Disorders
Updated: 1/1/1970
Managing Chronic Pain in Veterans With Substance Use Disorders
Status: Archived
Updated: 1/1/1970
Gene Therapy for Painful Diabetic Neuropathy
A Phase I/II, Open Label, Dose-Escalation Study to Assess the Safety and Tolerability of VM202 in Patients With Painful Diabetic Peripheral Neuropathy
Status: Archived
Gene Therapy for Painful Diabetic Neuropathy
Updated: 1/1/1970
A Phase I/II, Open Label, Dose-Escalation Study to Assess the Safety and Tolerability of VM202 in Patients With Painful Diabetic Peripheral Neuropathy
Status: Archived
Updated: 1/1/1970
Gene Therapy for Painful Diabetic Neuropathy
A Phase I/II, Open Label, Dose-Escalation Study to Assess the Safety and Tolerability of VM202 in Patients With Painful Diabetic Peripheral Neuropathy
Status: Archived
Gene Therapy for Painful Diabetic Neuropathy
Updated: 1/1/1970
A Phase I/II, Open Label, Dose-Escalation Study to Assess the Safety and Tolerability of VM202 in Patients With Painful Diabetic Peripheral Neuropathy
Status: Archived
Updated: 1/1/1970
Study Evaluating Heated Lidocaine/Tetracaine Patch in Patients With Pain Associated With Myofascial Trigger Points
An Open-label Pilot Study Evaluating Synera® in the Treatment of Patients With Pain Associated With Myofascial Trigger Points
Status: Archived
Study Evaluating Heated Lidocaine/Tetracaine Patch in Patients With Pain Associated With Myofascial Trigger Points
Updated: 1/1/1970
An Open-label Pilot Study Evaluating Synera® in the Treatment of Patients With Pain Associated With Myofascial Trigger Points
Status: Archived
Updated: 1/1/1970
Acupuncture for Chronic Pain
Acupuncture to Decrease Disparities in Outcomes of Pain Treatment
Status: Archived
Acupuncture for Chronic Pain
Updated: 1/1/1970
Acupuncture to Decrease Disparities in Outcomes of Pain Treatment
Status: Archived
Updated: 1/1/1970
Self-Directed Exercise Program for Adults With Arthritis
Evaluation of a Self-directed, Packaged Physical Activity Program for Adults With Arthritis
Status: Archived
Self-Directed Exercise Program for Adults With Arthritis
Updated: 1/1/1970
Evaluation of a Self-directed, Packaged Physical Activity Program for Adults With Arthritis
Status: Archived
Updated: 1/1/1970
L-Tyrosine Supplementation in Patients With Fibromyalgia
L-Tyrosine Supplementation in Patients With Fibromyalgia
Status: Archived
L-Tyrosine Supplementation in Patients With Fibromyalgia
Updated: 1/1/1970
L-Tyrosine Supplementation in Patients With Fibromyalgia
Status: Archived
Updated: 1/1/1970
Treatment of Fibromyalgia Using Deep Shaped-Field Transcranial Magnetic Stimulation a Clinical Feasibility Study
Treatment of Fibromyalgia Using Deep Shaped-Field (DSF) Transcranial Magnetic Stimulation (TMS): A Clinical Feasibility Study
Status: Archived
Treatment of Fibromyalgia Using Deep Shaped-Field Transcranial Magnetic Stimulation a Clinical Feasibility Study
Updated: 1/1/1970
Treatment of Fibromyalgia Using Deep Shaped-Field (DSF) Transcranial Magnetic Stimulation (TMS): A Clinical Feasibility Study
Status: Archived
Updated: 1/1/1970
The Effect of Nitroprusside on Intrauterine Device (IUD) Insertion
The Effect of Nitroprusside on the IUD Insertion Experience in Nulliparous Women: a Pilot Study
Status: Archived
The Effect of Nitroprusside on Intrauterine Device (IUD) Insertion
Updated: 1/1/1970
The Effect of Nitroprusside on the IUD Insertion Experience in Nulliparous Women: a Pilot Study
Status: Archived
Updated: 1/1/1970
Evaluation of Magnetic Fields to Treat Fibromyalgia
A Randomized, Double-blind, Placebo-controlled Evaluation of the Application of Magnetic Fields Using the Resonator Device for the Treatment of Fibromyalgia: Pilot Study Protocol
Status: Archived
Evaluation of Magnetic Fields to Treat Fibromyalgia
Updated: 1/1/1970
A Randomized, Double-blind, Placebo-controlled Evaluation of the Application of Magnetic Fields Using the Resonator Device for the Treatment of Fibromyalgia: Pilot Study Protocol
Status: Archived
Updated: 1/1/1970
Study of Proteins Associated With Complex Regional Pain Syndrome
Updated: 12/31/1969
Complex Regional Pain Syndrome Proteomics Study
Status: Enrolling
Updated: 12/31/1969
Study of Proteins Associated With Complex Regional Pain Syndrome
Updated: 12/31/1969
Complex Regional Pain Syndrome Proteomics Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
FDG-PET Imaging in Painful Joint Prosthesis
Updated: 12/31/1969
FDG-PET Imaging in Painful Joint Prosthesis (Protocol Amendment, Version 11, Dated 9/2005)
Status: Enrolling
Updated: 12/31/1969
FDG-PET Imaging in Painful Joint Prosthesis
Updated: 12/31/1969
FDG-PET Imaging in Painful Joint Prosthesis (Protocol Amendment, Version 11, Dated 9/2005)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurotropin Treatment of Fibromyalgia
Updated: 12/31/1969
Neurotropin Treatment of Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
Neurotropin Treatment of Fibromyalgia
Updated: 12/31/1969
Neurotropin Treatment of Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Pilot Study of TMS Effects on Pain and Depression in Patients With Fibromyalgia
Updated: 12/31/1969
A Pilot Study of Transcranial Magnetic Stimulation (TMS) Effects on Pain and Depression in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
A Pilot Study of TMS Effects on Pain and Depression in Patients With Fibromyalgia
Updated: 12/31/1969
A Pilot Study of Transcranial Magnetic Stimulation (TMS) Effects on Pain and Depression in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pain Responses in Patients on Long-Term Opioid Therapy for Chronic Pain
Updated: 12/31/1969
Pain Responses in Patients on Long-Term Opioid Therapy for Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Pain Responses in Patients on Long-Term Opioid Therapy for Chronic Pain
Updated: 12/31/1969
Pain Responses in Patients on Long-Term Opioid Therapy for Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An fMRI Study Of Brain Response In Patients With Fibromyalgia
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Cross-Over Study In Fibromyalgia Subjects To Examine Effects Of Pregabalin On Brain Response To Mechanical Pain As Assessed By Functional Magnetic Resonance Imaging, Proton Magnetic Resonance Spectroscopy And Subjective Ratings
Status: Enrolling
Updated: 12/31/1969
An fMRI Study Of Brain Response In Patients With Fibromyalgia
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Cross-Over Study In Fibromyalgia Subjects To Examine Effects Of Pregabalin On Brain Response To Mechanical Pain As Assessed By Functional Magnetic Resonance Imaging, Proton Magnetic Resonance Spectroscopy And Subjective Ratings
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Effect of Ketamine on Opioid-Induced Hyperalgesia
Updated: 12/31/1969
Effect of Ketamine on Opioid-Induced Hyperalgesia
Status: Enrolling
Updated: 12/31/1969
Effect of Ketamine on Opioid-Induced Hyperalgesia
Updated: 12/31/1969
Effect of Ketamine on Opioid-Induced Hyperalgesia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pain Quality Study
Updated: 12/31/1969
Pain Quality in Individuals With Low Back Pain, Headache, and Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
Pain Quality Study
Updated: 12/31/1969
Pain Quality in Individuals With Low Back Pain, Headache, and Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Use of Near Infrared Spectroscopy to Detect Muscle Perfusion in the Lower Extremity of Uninjured Subjects
Updated: 12/31/1969
Use of Near Infrared Spectroscopy to Detect Muscle Perfusion in the Lower Extremity of Uninjured Subjects
Status: Enrolling
Updated: 12/31/1969
Use of Near Infrared Spectroscopy to Detect Muscle Perfusion in the Lower Extremity of Uninjured Subjects
Updated: 12/31/1969
Use of Near Infrared Spectroscopy to Detect Muscle Perfusion in the Lower Extremity of Uninjured Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
Updated: 12/31/1969
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
Updated: 12/31/1969
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
Updated: 12/31/1969
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
Updated: 12/31/1969
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
Updated: 12/31/1969
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
Updated: 12/31/1969
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
Updated: 12/31/1969
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
Updated: 12/31/1969
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
Updated: 12/31/1969
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
Updated: 12/31/1969
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
Updated: 12/31/1969
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
Updated: 12/31/1969
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
Updated: 12/31/1969
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
Updated: 12/31/1969
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
Updated: 12/31/1969
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
Updated: 12/31/1969
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
Updated: 12/31/1969
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
Updated: 12/31/1969
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
Updated: 12/31/1969
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
Updated: 12/31/1969
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
Updated: 12/31/1969
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
Updated: 12/31/1969
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials